Parkinson's disease: An endogenous protein might become a candidate for drug development
Bionity,
Researchers have modified the protein Nurr1 so that it can enter cells from the outside.
Researchers have modified the protein Nurr1 so that it can enter cells from the outside.
Bochum, Germany (Scicasts) — Researchers have modified the protein Nurr1 so that it can enter cells from the outside.
The Bochum team: Sebastian Neumann, Rolf Heumann, Dennis Paliga, and Fabian Raudzus.
rzte Zeitung online, 03.09.2018 Nurr1 Ein Transkriptionsfaktor könnte als Medikament bei Morbus Parkinson infrage kommen.